Literature DB >> 28782798

Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma.

T Maeta1, T Ebata1, E Hayashi2, T Kawahara3, S Mizuno4, N Matsumoto5, S Ohta6, M Nagino1.   

Abstract

BACKGROUND: Little is known about the value of portal vein (PV) resection in distal cholangiocarcinoma. The aim of this study was to evaluate the clinical significance of PV resection in distal cholangiocarcinoma.
METHODS: Patients who underwent pancreatoduodenectomy (PD) for distal cholangiocarcinoma between 2001 and 2010 at one of 31 hospitals in Japan were reviewed retrospectively with special attention to PV resection. Short- and long-term outcomes were evaluated.
RESULTS: In the study interval, 453 consecutive patients with distal cholangiocarcinoma underwent PD, of whom 31 (6·8 per cent) had combined PV resection. The duration of surgery (510 versus 427 min; P = 0·005) and incidence of blood transfusion (48 versus 30·7 per cent; P = 0·042) were greater in patients who had PV resection than in those who did not. Postoperative morbidity and mortality were no different in the two groups. Several indices of tumour progression, including high T classification, lymphatic invasion, perineural invasion, pancreatic invasion and lymph node metastasis, were more common in patients who had PV resection. Consequently, the incidence of R1/2 resection was higher in this group (32 versus 11·8 per cent; P = 0·004). Survival among the 31 patients with PV resection was worse than that for the 422 patients without PV resection (15 versus 42·4 per cent at 5 years; P < 0·001). Multivariable analyses revealed that age, blood loss, histological grade, perineural invasion, pancreatic invasion, lymph node metastasis and surgical margin were independent risk factors for overall survival. PV resection was not an independent risk factor.
CONCLUSION: PV invasion in distal cholangiocarcinoma is associated with locally advanced disease and several negative prognostic factors. Survival for patients who have PV resection is poor even after curative resection.
© 2017 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28782798     DOI: 10.1002/bjs.10596

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Impact of the preoperative body composition indexes on intraoperative blood loss in patients undergoing pancreatoduodenectomy.

Authors:  Kenta Ishii; Yukihiro Yokoyama; Tomoki Ebata; Tsuyoshi Igami; Takashi Mizuno; Junpei Yamaguchi; Shunsuke Onoe; Nobuyuki Watanabe; Masato Nagino
Journal:  Surg Today       Date:  2020-06-20       Impact factor: 2.549

2.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

3.  Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma.

Authors:  Tianyi Fang; Hao Wang; Yunfu Cui; Zhidong Wang; Yufu Wang; Xuan Lin
Journal:  Dis Markers       Date:  2019-02-04       Impact factor: 3.464

4.  Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy.

Authors:  Shaocheng Lyu; Lixin Li; Xin Zhao; Zhangyong Ren; Di Cao; Qiang He
Journal:  World J Surg Oncol       Date:  2020-10-08       Impact factor: 2.754

5.  The Impact of Intraoperative Frozen Section on Resection Margin Status and Survival of Patients Underwent Pancreatoduodenectomy for Distal Cholangiocarcinoma.

Authors:  Zhiqiang Chen; Bingran Yu; Jiaping Bai; Qiong Li; Bowen Xu; Zhaoru Dong; Xuting Zhi; Tao Li
Journal:  Front Oncol       Date:  2021-05-03       Impact factor: 6.244

6.  Prognostic Value of Carbohydrate Antigen 19-9 and the Surgical Margin in Extrahepatic Cholangiocarcinoma.

Authors:  Ryusei Yamamoto; Teiichi Sugiura; Ryo Ashida; Katsuhisa Ohgi; Mihoko Yamada; Shimpei Otsuka; Katsuhiko Uesaka
Journal:  Ann Gastroenterol Surg       Date:  2021-11-09

7.  Portal vein wedge resection and patch venoplasty using autologous and homologous vein grafts during surgery for hepatobiliary malignancies.

Authors:  Byeong-Gon Na; Shin Hwang; Dong-Hwan Jung; Sung-Gyu Lee
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-11-30

8.  Relevant prognostic factors influencing outcome of patients after surgical resection of distal cholangiocarcinoma.

Authors:  Oliver Beetz; Michael Klein; Harald Schrem; Jill Gwiasda; Florian W R Vondran; Felix Oldhafer; Sebastian Cammann; Jürgen Klempnauer; Karl J Oldhafer; Moritz Kleine
Journal:  BMC Surg       Date:  2018-08-13       Impact factor: 2.102

9.  Tranexamic ACid during PancereaticoDuodenectomy (TAC-PD): study protocol for a multicentre randomised, blind, placebo-controlled trial.

Authors:  Kenta Ishii; Yukihiro Yokoyama; Yoshihiko Yonekawa; Tomoki Ebata
Journal:  BMJ Open       Date:  2020-11-03       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.